net income included $num-one million of net after-tax realized capital losses compared to $num-two million of capital gains in the first quarter last year.
this compares to net income of $num-one million for the first quarter of year-four.
everest reported net income of $num-one million for the first quarter of year-five.
shareholders' equity for the group was $num-one billion at the end of the first quarter, down from $num-two billion at year-end year-four.
net investment income of $num-one million was up num-two% from the first quarter of year-four.
additionally, everest remains resilient, as reflected by both our num-one% growth rate in gross written premium and by our capital position.
excluding the pandemic ibnr loss estimate, the attritional loss ratio was num-one%, up from num-two% for the full year year-four primarily due to the continued change in business mix.
the combined ratio was num-one% for the first quarter of year-five compared to num-two% for the first quarter of year-four.
despite the pandemic and the economic downturn, everest remains profitable, as reflected in our reported num-one% combined ratio or num-two% excluding catastrophe losses and the pandemic ibnr loss provision.
this is an improvement from the fourth quarter of year-four where the rate increase was almost plus num-one% excluding workers' compensation and plus num-two% all in.
operating income for the quarter was $num-one million driven by strong underwriting results across the group, stable net investment income and lower catastrophe losses, offset by a covid pandemic ibnr loss estimate of $num-two million.
as per our [date] announcement, we have taken $num-one million ibnr loss provision in the first quarter related to the covid pandemic.
positive cash flow continues with operating cash flow of $num-one million compared to $num-two million for the first quarter of year-four.
for the insurance segment, the attritional loss ratio, excluding the pandemic loss estimate, remained very steady at num-one%, essentially flat compared to num-two% for the full year year-four.
we demonstrated excellent momentum across both of our reinsurance and insurance businesses with gross written premium growth of num-one% and num-two%, respectively.
only a very small number of policies have endorsed sublimits typically less than $num-one and with short-duration caps that would offer bi for a notable notifiable human disease.